Home › Hereditary Sensory and Autonomic Neuropathies › Minnesota
Hereditary Sensory and Autonomic Neuropathies clinical trials in Minnesota
3 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in Minnesota.
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Minnesota Oncology Hematology, Maple Grove
- Mayo Clinic (Minnesota), Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Minnesota Oncology Hematology, P.A., Maple Grove
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.